Telix Pharmaceuticals Limited Stock
Stocks
TLX
AU000000TLX2
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.36 AUD | -2.04% |
|
+5.86% | +37.05% |
| 06-23 | ASX Biggest Gainers | MT |
| 06-02 | Telix Pharmaceuticals, United Imaging Healthcare Sign MOU for US Theranostics Collaboration; Shares Down 3% | MT |
| Market Cap | 5.32B 3.68B 3.23B 2.98B 2.79B 5.23B 347B 35.75B 13.85B 171B 13.83B 13.52B 595B | P/E 2026 * |
1,052x | P/E 2027 * | 111x |
|---|---|---|---|---|---|
| Enterprise Value | 5.73B 3.96B 3.48B 3.21B 3B 5.63B 374B 38.49B 14.91B 184B 14.89B 14.56B 641B | EV / Sales 2026 * |
4.21x | EV / Sales 2027 * | 3.62x |
| Free-Float |
83.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | -2.10% | ||
| 1 week | +5.86% | ||
| Current month | +17.81% | ||
| 1 month | +16.02% | ||
| 3 months | +18.81% | ||
| 6 months | +30.42% | ||
| Current year | +37.05% |
| 1 week | 14.07 |  | 16.06 |
| 1 month | 12.17 | | 16.06 |
| Current year | 8.26 | | 16.06 |
| 1 year | 8.26 | | 25.87 |
| 3 years | 8.2 | | 31.97 |
| 5 years | 3.55 | | 31.97 |
| 10 years | 0.46 | | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2017-01-02 | |
Darren Smith
DFI | Director of Finance/CFO | 60 | 2022-07-30 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Gill
BRD | Director/Board Member | 71 | 2026-05-10 |
William Jellison
BRD | Director/Board Member | 68 | 2026-05-10 |
| Director/Board Member | 51 | 2017-01-02 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-10 | Buy | Director | 10,200 | 0.0030% | ||
| 05-25 | Free | Director | 30,048 | 0.0089% | ||
| 05-25 | Free | Director | 21,597 | 0.0064% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.04% | +5.86% | -37.93% | +32.79% | 3.68B | |
| +1.67% | +9.28% | -5.05% | +1.40% | 45.45B | |
| +4.95% | +9.31% | +363.86% | +598.16% | 36.09B | |
| -0.64% | +1.92% | +3.08% | +53.58% | 30.81B | |
| +0.44% | +11.12% | +17.47% | -12.91% | 30.98B | |
| +0.23% | -0.29% | +13.24% | +21.10% | 24.62B | |
| +9.90% | +13.32% | - | - | 14.78B | |
| +1.40% | +12.99% | +67.11% | +132.76% | 14.65B | |
| +1.88% | +8.59% | +13.76% | +20.68% | 13.3B | |
| +2.38% | +5.69% | +95.85% | +97.63% | 12.65B | |
| Average | +2.01% | +7.17% | +59.04% | +105.02% | 22.7B | |
| Weighted average by Cap. | +2.06% | +6.84% | +75.88% | +127.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.36B 941M 827M 762M 712M 1.34B 88.82B 9.14B 3.54B 43.78B 3.53B 3.46B 152B | 1.59B 1.1B 969M 892M 834M 1.57B 104B 10.71B 4.15B 51.29B 4.14B 4.05B 178B |
| Net income | 5.83M 4.04M 3.54M 3.27M 3.05M 5.73M 381M 39.19M 15.18M 188M 15.15M 14.82M 652M | 43.23M 29.91M 26.28M 24.21M 22.64M 42.46M 2.82B 290M 113M 1.39B 112M 110M 4.84B |
| Net Debt | 408M 282M 248M 229M 214M 401M 26.65B 2.74B 1.06B 13.14B 1.06B 1.04B 45.66B | 447M 310M 272M 251M 234M 439M 29.21B 3.01B 1.16B 14.4B 1.16B 1.14B 50.04B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-25 | A$15.36 | -2.04% | 333,276 |
| 26-06-25 | A$15.68 | -0.32% | 1,745,963 |
| 26-06-24 | A$15.73 | +8.04% | 3,701,343 |
| 26-06-23 | A$14.56 | +2.46% | 1,878,642 |
| 26-06-22 | A$14.21 | -2.00% | 1,273,119 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
